Search

Your search keyword '"Ashford, Fiona"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Ashford, Fiona" Remove constraint Author: "Ashford, Fiona"
45 results on '"Ashford, Fiona"'

Search Results

1. Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

3. SARS-CoV-2 Testing in the Community: Testing Positive Samples with the TaqMan SARS-CoV-2 Mutation Panel To Find Variants in Real Time

4. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

6. Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells

7. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

8. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

9. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

11. Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion

13. PDX1LOW MAFALOW β-cells contribute to islet function and insulin release

14. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics

15. Author Correction: Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics

16. Cysteine post-translational modifications regulate protein interactions of caveolin-3.

17. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

19. Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning

20. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

21. Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study

22. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD Study

23. Molecular Architecture of Androgen Receptor Pathways Amplifying Glucagon-Like Peptide-1 Insulinotropic Action in Male Pancreatic β-Cells

24. The Impact of Pausing Bruton Tyrosine Kinase Inhibitor Therapy and Responsiveness of Vaccination in Blood Cancer Patients: Primary Outcome Result for the Randomised Improve Trial

25. Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key

26. Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist

27. S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction

28. Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.

29. S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-QPCR

30. Validation testing to determine the effectiveness of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings

31. Mature and immature β-cells both contribute to islet function and insulin release

33. Vitamin D-binding protein is required for the maintenance of α-cell function and glucagon secretion

34. Vitamin D-binding protein is required for the maintenance of [alpha]-cell identity and function

36. LUXendins reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics

38. Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance

42. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics

43. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics

44. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics

45. PDX1LOW MAFALOW β-cells contribute to islet function and insulin release

Catalog

Books, media, physical & digital resources